FDA Approves Unknown Drug — INGENUS PHARMS LLC

On January 9, 2019, INGENUS PHARMS LLC received FDA approval for ANDA #210985, a move that positions the company to leverage significant market opportunities by filling a therapeutic gap for this未指定药物。